BioCatch key facts
as of Oct 2026- Developer of behavioral biometrics and digital fraud detection software intended for financial institutions globally.
- BioCatch is valued at approximately $1.3B as of Oct 2026 (last reported valuation).
- It has raised $239.3M; the latest was PE Growth/Expansion in Mar 2025.
- Notable investors include Sapphire Ventures, Macquarie Capital, Permira, Alanda Capital Management, Wyndham Wealth — 6 tracked in total.
- Status: Privately Held (backing).
BioCatch's last reported valuation, Aug 2024. Nothing priced has surfaced since.
- ·Watch BioCatch: the Monday email on marks, rounds and moves
BioCatch funding rounds
No funding rounds for BioCatch are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
BioCatch valuation
BioCatch's last reported valuation was $1.3 billion in Aug 2024. No priced round, secondary trade or fund mark has surfaced since.
BioCatch investors
6 investors are on record for BioCatch, including Sapphire Ventures, Macquarie Capital, Permira and Alanda Capital Management. By type, the record holds 3 venture capital firms, 1 hedge fund and 1 private equity firm.
About BioCatch
Developer of behavioral biometrics and digital fraud detection software intended for financial institutions globally. The company uses machine learning models that analyze user interactions, such as keystroke patterns, mouse movements, touch screen behavior, device attributes, and transaction context to identify abnormal activity and help financial institutions detect fraud and financial crime during digital banking sessions.
- Sector
- Information Technology
- HQ
- Tel Aviv, Israel
- Founded
- 2011
- Employees
- 400
- Website
- biocatch.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.